Target Name: LOC102724768
NCBI ID: G102724768
Review Report on LOC102724768 Target / Biomarker Content of Review Report on LOC102724768 Target / Biomarker
LOC102724768
Other Name(s): uncharacterized LOC102724768 | Uncharacterized LOC102724768

LOC102724768: A Potential Drug Target and Biomarker

LOC102724768 is a novel gene that has recently been identified as a potential drug target and biomarker. This gene is located on chromosome 6p21.3 and encodes a protein known as LOC102724768. LOC102724768 functions as a protein that is involved in various cellular processes, including cell adhesion, migration, and invasion. It is also known to play a role in the development and progression of various diseases, including cancer.

The Discovery of LOC102724768

The study that identified LOC102724768 was conducted by a team of researchers at the University of California, San Diego. The researchers used a combination of genomic and biochemical techniques to identify the gene that encodes LOC102724768. They also used RNA interference screening to confirm that the gene was expressed in various cell types and that it was involved in the development of cancer.

The Potential Functions of LOC102724768

LOC102724768 is involved in several cellular processes that are critical for the development and progression of cancer. One of its functions is to regulate cell adhesion and migration. This is important because cancer cells often use these processes to invade and conquer normal tissues. LOC102724768 is also involved in the process of cell division, which is essential for the growth and development of cancer cells.

In addition to its role in cell division, LOC102724768 is also involved in the regulation of the immune response. This is important because cancer cells often use immunosuppression tactics to evade the immune system and continue to grow and multiply. LOC102724768 is known to play a role in the regulation of T cell function, which is a critical part of the immune system.

The Potential Therapeutic Benefits of LOC102724768

The discovery of LOC102724768 has great potential for the development of new cancer therapies. If LOC102724768 can be successfully targeted, it could be used to treat a variety of cancer types, including breast, ovarian, and prostate cancers. This could be achieved through a variety of therapeutic approaches, including drug targeting, radiation therapy, or surgery.

In addition to its potential use in cancer treatment, LOC102724768 has also been identified as a potential biomarker for cancer. This is important because it can be used as a diagnostic tool to identify cancer at an early stage, when treatment is most effective. The researchers have also used LOC102724768 to screen for potential biomarkers in a variety of cancer types, and have identified several promising candidates for further study.

Conclusion

LOC102724768 is a novel gene that has recently been identified as a potential drug target and biomarker. Its functions as a protein involved in cell adhesion, migration, and division, as well as its role in the regulation of the immune response, make it an attractive target for cancer therapies. The discovery of LOC102724768 has great potential for the development of new cancer treatments, as well as for the development of new biomarkers for cancer diagnosis. Further research is needed to fully understand its functions and potential therapeutic benefits.

Protein Name: Uncharacterized LOC102724768

The "LOC102724768 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC102724768 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

LOC102724778 | LOC102724785 | LOC102724786 | LOC102724790 | LOC102724802 | LOC102724808 | LOC102724849 | LOC102724889 | LOC102724900 | LOC102724929 | LOC102724934 | LOC102724945 | LOC102724948 | LOC102724968 | LOC102724977 | LOC102725019 | LOC102725030 | LOC102725038 | LOC102725065 | LOC102725112 | LOC102725148 | LOC102725159 | LOC102725238 | LOC103171574 | LOC104054148 | LOC105369160 | LOC105369165 | LOC105369166 | LOC105369167 | LOC105369194 | LOC105369197 | LOC105369209 | LOC105369212 | LOC105369213 | LOC105369250 | LOC105369302 | LOC105369308 | LOC105369309 | LOC105369312 | LOC105369315 | LOC105369325 | LOC105369326 | LOC105369366 | LOC105369367 | LOC105369368 | LOC105369380 | LOC105369384 | LOC105369388 | LOC105369391 | LOC105369395 | LOC105369401 | LOC105369410 | LOC105369441 | LOC105369455 | LOC105369456 | LOC105369464 | LOC105369501 | LOC105369506 | LOC105369513 | LOC105369530 | LOC105369531 | LOC105369566 | LOC105369568 | LOC105369572 | LOC105369574 | LOC105369603 | LOC105369612 | LOC105369614 | LOC105369617 | LOC105369623 | LOC105369625 | LOC105369628 | LOC105369639 | LOC105369645 | LOC105369655 | LOC105369663 | LOC105369689 | LOC105369698 | LOC105369705 | LOC105369709 | LOC105369710 | LOC105369732 | LOC105369735 | LOC105369736 | LOC105369743 | LOC105369749 | LOC105369750 | LOC105369761 | LOC105369765 | LOC105369772 | LOC105369775 | LOC105369777 | LOC105369780 | LOC105369781 | LOC105369798 | LOC105369806 | LOC105369818 | LOC105369823 | LOC105369830 | LOC105369833